Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2018, Scanderia Venture is a venture capital firm based in Białystok, Poland. The firm focuses on supporting innovative projects in life sciences, medtech, healthcare, and ICT. Scanderia Venture manages a portfolio of 9 companies and engages in initiatives co-financed by the European Union.
Scanderia Venture invests in startups at the pre-seed and seed stages, with a maximum investment of €250,000. The firm targets sectors such as medtech, biomedical engineering, biological products, and ICT solutions that enhance healthcare. Their goal is to support projects with potential for global commercialization.
Notable companies in Scanderia Venture's portfolio include Aveye, Coviar, Elbiotech, and MEDCool. These startups represent a range of innovative solutions in the biotech and healthcare sectors.
Submit your pitch through their website's contact form for consideration.
Scanderia Venture operates the 'Scanderia Venture - Incubator of R&D Projects in the Life Science, IoT, and ICT Sectors,' which is co-financed by the European Union. This program supports innovative projects in relevant fields.
Yes, Scanderia Venture often leads investment rounds in the startups they support, particularly in the pre-seed and seed stages.
The firm is open to follow-on investments, especially for startups that demonstrate significant growth and potential for commercialization.
Specific details about the fund size are not publicly disclosed, but the firm typically invests up to €250,000 per startup.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.